7 completed. 7 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 3 | 3 | Completed 3 |
Follow Hyperparathyroidism, Primary: new trials by email Literature Review of Hyperparathyroidism, Primary trials Research Report on Hyperparathyroidism, Primary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 18F-Fluorocholine for the Detection of Parathyroid Adenomas 18F-Fluorocholine, Positron Emission Tomography (PET) - Hyperparathyroidism, Primary | Phase 2 / Phase 3 | Completed | Thomas Hope | 98 | 2016-09-21 | 2021-10-19 |
| Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism eplerenone, amiloride, Placebo - Primary Hyperparathyroidism | Phase 2 / Phase 3 | Completed | Brigham and Women's Hospital | 69 | 2016-01-01 | 2023-05-03 |
| Effect of Vitamin D Treatment in Primary Hyperparathyroidism Cholecalciferol - Vitamin D Deficiency, Primary Hyperparathyroidism | Phase 2 / Phase 3 | Completed | University of Aarhus | 46 | 2008-05-01 | 2013-11-18 |
| A Multicenter, Open-label Extension Study to Assess the Long-term Safety and Efficacy of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism cinacalcet - Hyperparathyroidism, Primary | Phase 2 | Completed | Amgen | 45 | 2000-11-01 | 2013-05-08 |
| Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT) Cinacalcet, Placebo - Primary Hyperparathyroidism | Phase 2 | Completed | Amgen | 10 | 2000-06-15 | 2018-12-14 |
| A Study to Assess the Efficacy and Safety of Twice-Daily Dose Regimens of an Oral Calcimimetic Agent AMG 073 (Cinacalcet) in Primary Hyperparathyroidism (PHPT) placebo, cinacalcet - Hyperparathyroidism, Primary | Phase 2 | Completed | Amgen | 78 | 1999-11-01 | 2013-05-08 |
| Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism Cinacalcet, Placebo - Primary Hyperparathyroidism | Phase 2 | Completed | Amgen | 48 | 1998-09-29 | 2018-12-13 |
Hypercalcemia (1) · Vitamin D Deficiency (1)
Endocrine System Diseases (7) · Hyperparathyroidism (7) · Parathyroid Diseases (7) · Avitaminosis (1) · Calcium Metabolism Disorders (1) · Deficiency Diseases (1) · Malnutrition (1) · Metabolic Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Water-Electrolyte Imbalance (1)
Cinacalcet (5) · Amiloride (1) · Cholecalciferol (1) · Eplerenone (1) · Magnetic Resonance Spectroscopy (1) · Vitamin D (1) · fluorocholine (1)
Amgen (4) · Brigham and Women's Hospital (1) · Thomas Hope (1) · University of Aarhus (1)
United States (2) · Denmark (1)
Anand Vaidya, MD MMSc (1) · Lars Rejnmark, MD,PhD,DrMed (1) · Lars Rolighed, MD (1) · Thomas Hope, MD (1)